**Research Highlights**

(1)There have been few reports describing the mechanism by which *Buyang Huanwu* Decoction can promote neurogenesis in ischemic cerebral tissue. Most previous studies regarding the effects of *Buyang Huanwu* Decoction on cerebral ischemia have investigated the effects of *Buyang Huanwu* Decoction on angiogenesis and the recovery of injured cerebral tissue.(2)This study aimed to investigate the effects of *Buyang Huanwu* Decoction on the proliferation and neuronal differentiation of neural stem cells.

INTRODUCTION {#sec1-1}
============

Recent studies have shown that cerebral ischemia induces neurogenesis in neuroproliferative regions of the adult rodent brain, including the subventricular zone, the subgranular zone of the dentate gyrus, and the peri-infarct area\[[@ref1][@ref2][@ref3][@ref4]\]. In addition, endogenous neurogenesis cannot be regulated by drugs but can be controlled by intrinsic genetic mechanisms and growth factors\[[@ref5][@ref6][@ref7]\]. Growth-associated protein 43 (GAP-43) is a nervous tissue-specific cytoplasmic protein that modulates synaptic plasticity\[[@ref8]\]. During development, GAP-43 expression in the brain is high and declines in mature neurons during adulthood; during neurogenesis, GAP-43 expression is significantly upregulated in proliferating neuroblasts and differentiating neurons\[[@ref9][@ref10][@ref11]\]. Therefore, GAP-43 has been designated as a 'growth' or 'plasticity' protein\[[@ref12][@ref13][@ref14]\].

*Buyang Huanwu* Decoction (BYHWD) is a classic herbal formula of traditional Chinese medicine that has been shown to improve neurological function in stroke patients\[[@ref12]\]. In experimental studies, *Buyang Huanwu* Decoction has been shown to reduce infarct volume\[[@ref13]\], attenuate the number of apoptotic cells, and suppress the expression of the caspase-3 cleavage product caspase-3p20\[[@ref14]\]. In addition, *Buyang Huanwu* Decoction has been used to culture neural stem cells derived from the embryonic hippocampus\[[@ref15][@ref16][@ref17]\].

In this study, we investigated the effect of *Buyang Huanwu* Decoction on the proliferation and differentiation of neural stem cells, and on the expression of GAP-43 in ischemic brain.

RESULTS {#sec1-2}
=======

Quantitative analysis of experimental animals {#sec2-1}
---------------------------------------------

A total of 128 male rats were randomly and equally divided into four groups: a normal group, a sham surgery group, a middle cerebral artery occlusion (MCAO) group, and a MCAO + *Buyang Huanwu* Decoction group. One rat separately from each of the MCAO and MCAO + *Buyang Huanwu* Decoction groups died from hemorrhage of the middle cerebral artery. One rat separately from each of the MCAO and MCAO + *Buyang Huanwu* Decoction groups died of unknown causes 2 days after surgery. These four animals were excluded, and no rats were lost in the normal and sham operated groups. Rats in the MCAO + *Buyang Huanwu* Decoction group were intragastrically fed 5 g/kg *Buyang Huanwu* Decoction for 1, 7, 14 and 28 days (*n* = 8 rats/time point), once per day, and in the other groups, rats were given the same volume of distilled water at each time point (*n* = 6 rats/time point). All 96 rats were included in the final analysis.

*Buyang Huanwu* Decoction promoted the proliferation of neural stem cells in ischemic brain tissue {#sec2-2}
--------------------------------------------------------------------------------------------------

At 1 day after intragastric administration, the number of nestin-positive cells was increased in the cerebral cortex, the subventricular zone and the dentate gyrus of the ipsilateral hippocampus in the MCAO and MCAO + *Buyang Huanwu* Decoction groups ([Figure 1](#F1){ref-type="fig"}). In the MCAO and MCAO + *Buyang Huanwu* Decoction groups, the number of nestin-positive cells in the cerebral cortex reached its peak at 14 days (*P* \< 0.05) and decreased at 28 days (*P* \< 0.05). At 7, 14 and 28 days after intragastric administration, the number of nestin-positive cells in the cerebral cortex in the MCAO + *Buyang Huanwu* Decoction group was significantly higher than that in the MCAO group (*P* \< 0.05; [Figure 1](#F1){ref-type="fig"}). These findings suggest that *Buyang Huanwu* Decoction can promote the proliferation of neural stem cells.

![Effects of *Buyang Huanwu* Decoction (BYHWD) on the proliferation of neural stem cells in the infarct periphery after cerebral ischemia.\
(A--J) Immunohistochemical staining of nestin-positive cells (red) in the middle cerebral artery occlusion (MCAO) group (cerebral cortex or subventricular zone at 1 day and hippocampus at 7 days) and MCAO + BYHWD group (cerebral cortex or subventricular zone at 1 day and hippocampus at 7 days) after cerebral ischemia (× 200; scale bars: 50 μm).\
(K) Quantification of nestin-positive cells in the cerebral cortex. ^a^*P* \< 0.05, *vs*. normal group; ^b^*P* \< 0.05, *vs*. MCAO group (mean ± SD; *n* = 6 rats in each group, Student\'s *t*-test).](NRR-8-2336-g001){#F1}

*Buyang Huanwu* Decoction promoted neuronal differentiation of neural stem cells in ischemic brain tissue {#sec2-3}
---------------------------------------------------------------------------------------------------------

5-Bromodeoxyuridine (BrdU)/microtubule- associated protein-2 (MAP-2) double-labeled cells were not present in the normal and sham operated groups. At 1 day after intragastric administration, few BrdU/ MAP-2 double-labeled cells were observed in the subventricular zone and cerebral cortex of rats in the MCAO and MCAO + *Buyang Huanwu* Decoction groups. The number of double-labeled cells increased at 7 days, peaked at 14 days (*P* \< 0.05) and decreased at 28 days (*P* \< 0.05). There were a few BrdU/ MAP-2 double-labeled cells in the ipsilateral hippocampal dentate gyrus in both groups ([Figure 2](#F2){ref-type="fig"}).

![Effects of *Buyang Huanwu* Decoction (BYHWD) on the quantity of newly regenerated neurons in the cerebral cortex of rats with cerebral ischemia.\
(A--L) Immunohistochemical staining of microtubule-associated protein-2 (MAP2)/5-bromodeoxyuridine (BrdU) double-stained cells in the subventricular zone (14 days), hippocampus (7 days) or in the cerebral cortex (7 and 14 days) after cerebral ischemia (× 400; scale bars: 25 μm).\
(M) Quantification of MAP2/BrdU double-stained cells. ^a^*P* \< 0.05, *vs*. middle cerebral artery occlusion (MCAO) group (mean ± SD; *n* = 6 rats in each group, Student\'s *t*-test).](NRR-8-2336-g002){#F2}

At 14 and 28 daysafter intragastric administration, the number of BrdU/MAP-2 double-labeled cells was significantly higher in the MCAO + *Buyang Huanwu* Decoction group than in the MCAO group ([Figure 2](#F2){ref-type="fig"}; *P* \< 0.05).

*Buyang Huanwu* Decoction regulated GAP-43 expression in ischemic brain {#sec2-4}
-----------------------------------------------------------------------

At 14 days after intragastric administration, the number of GAP-43-positive cells in the cerebral cortex and hippocampus in the MCAO and MCAO + *Buyang Huanwu* Decoction groups reached its peak and then decreased (*P* \< 0.05; [Figure 3A](#F3){ref-type="fig"}).

![Effects of *Buyang Huanwu* Decoction (BYHWD) on expression of growth associated protein-43 (GAP-43) in the cerebral cortex of rats with cerebral ischemia.\
(A--H) Immunohistochemical staining of GAP-43-positive cells in the cerebral cortex at 1, 7 and 14 days after cerebral ischemia in the middle cerebral artery occlusion (MCAO; C, E, G) and MCAO + BYHWD groups (D, F, H) and in the hippocampus at 14 days after cerebral ischemia in the MCAO (A) and MCAO + BYHWD groups (B) (counterstained with 3-amino-9-ethylcarbazole, × 400; scale bars: 25 μm).\
(I) Quantification of GAP-43-positive cell expression in the cerebral cortex. ^a^*P* \< 0.05, *vs*. normal group; ^b^*P* \< 0.05, *vs*. MCAO group (mean ± SD; *n* = six rats in each group per time point, Student\'s *t*-test).](NRR-8-2336-g003){#F3}

At 7, 14 and 28 days after intragastric administration, the number of GAP-43-positive cells in the MCAO + *Buyang Huanwu* Decoction group was significantly higher than that in the MCAO group (*P* \< 0.05; [Figure 3B](#F3){ref-type="fig"}).

DISCUSSION {#sec1-3}
==========

In this study, we revealed two major findings. First, *Buyang Huanwu* Decoction improved the proliferation and neuronal differentiation of neural stem cells in the brain after MCAO. Second, *Buyang Huanwu* Decoction increased the expression of GAP-43.

After stroke, a reduction in cerebral blood flow and consequent hypoxia trigger a complex pathophysiologic response, which leads to cell death and neurological function deficits. Current therapies include neuroprotection and thrombolysis, which are aimed at reducing neuron death and saving damaged cells. Neither therapy is capable of regenerating new neurons and repairing injured tissues\[[@ref18][@ref19]\]. Therapies that stimulate neurogenesis and rebuild the neural system remain to be developed for the treatment of stroke.

Traditionally, the mammalian adult central nervous system is viewed as having a lack of regenerative capacity. However, recent studies have demonstrated that the adult brain has regenerative areas that reside in the subventricular zone and the hippocampal dentate gyrus\[[@ref20][@ref21][@ref22][@ref23]\]. Neurogenesis involves neural stem/progenitor cell proliferation, migration and neural differentiation\[[@ref24]\]. Therefore, the effects of therapeutics at any stage of this complex process will have an impact on neurogenesis. Previous studies have detected few newly-generated neurons after cerebral ischemia\[[@ref6][@ref25]\]. More importantly, endogenous neurogenesis by neural stem/progenitor cells can be modulated by environmental factors and by administration of various pharmaceutical agents\[[@ref5][@ref6]\] and cytokines\[[@ref26][@ref27]\].

*Buyang Huanwu* Decoction is a well-known formula for stroke treatment in China, and it enhances the proliferation and differentiation of neural progenitor cells *in vitro*\[[@ref15]\]. In addition, *Buyang Huanwu* Decoction has been shown to have an anti-inflammatory effect and increase vascular endothelial growth factor expression after cerebral ischemia\[[@ref13][@ref28]\]. Inflammation after stroke impairs neurogenesis and inhibits microglial activation\[[@ref29]\], and vascular endothelial growth factor acts as a neurogenic factor, promoting neurogenesis in the brain after cerebral ischemia\[[@ref30]\]. Therefore, we presume that *Buyang Huanwu* Decoction can enhance neurogenesis. In the present study, we found that *Buyang Huanwu* Decoction can enhance the expression of nestin and the numbers of newborn neurons, which indicates that *Buyang Huanwu* Decoction can affect neural regeneration.

Re-establishing connections between newborn and neighboring cells after injury is important for neurological rehabilitation. GAP-43 is the most prominent molecule involved in neural regeneration\[[@ref31]\]. The expression of GAP-43 is high in the brain during development and declines in most neurons when mature synapses are formed. However, after cerebral ischemia, expression of GAP-43 increases\[[@ref32]\], and overexpression of GAP-43 has been shown to enhance neurite outgrowth *in vitro* and axonal sprouting *in vivo*\[[@ref33][@ref34]\]. Therefore, regulating GAP-43 can affect neurogenesis.

In summary, our present study revealed that there is limited neurogenesis after stroke. *Buyang Huanwu* Decoction enhanced neural stem cell proliferation and differentiation as well as the expression of GAP-43 in ischemic brain. However, further studies are required to understand its mechanism of action and neurological rehabilitation effect.

MATERIALS AND METHODS {#sec1-4}
=====================

Design {#sec2-5}
------

A randomized, controlled animal experiment.

Time and setting {#sec2-6}
----------------

Experiments were performed at Key Laboratory of Internal Medicine, Hunan University of Traditional Chinese Medicine, China from November 2009 to July 2011.

Materials {#sec2-7}
---------

### Animals {#sec3-1}

Adult male Wistar rats (*n* = 128), weighing 280--300 g, were obtained from Hunan Slac Jingda Laboratory Animal Company Ltd. (Changsha, China; license No. SCXK (Xiang) 2009-0004). Investigations using experimental animals were conducted in accordance with internationally accepted principles for laboratory animal use and care.

The experimental protocol was in accordance with *Guidance Suggestions for the Care and Use of Laboratory Animals* issued by Ministry of Science and Technology of the People\'s Republic of China\[[@ref35]\].

### Drugs {#sec3-2}

*Buyang Huanwu* Decoction was composed of *Astragalus membranaceus* (120 g), *Angelica sinensis* (10 g), *Paeonia lactiflora* (10 g), *Ligusticum chuanxiong* (10 g), *Carthamus tinctorius* (10 g), Semen Persicae (10 g) and *Flos carthami* (4.5 g). All of the herbal components (GAP grade) were purchased from the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, China. To ensure the consistency of the herbal formula, we made *Buyang Huanwu* drug extracts using standard methods described in the Chinese Pharmacopoeia (China Pharmacopoeia and Committee, 2000). *Buyang Huanwu* Decoction was obtained by boiling, concentrated to contain 2 g of crude material per liter, and stored at 4°C.

Methods {#sec2-8}
-------

### Preparation of rat models of local cerebral ischemia {#sec3-3}

Focal cerebral ischemia was induced by middle cerebral artery occlusion as described previously\[[@ref36]\]. Briefly, rats were intraperitoneally (i.p.) anesthetized with 400 mg/kg chloral hydrate. During surgery, rat body temperature was maintained at 37.0°C by placing animals on a heated bed. The right carotid bifurcation was exposed, and the external carotid artery was ligated distal to the bifurcation. A silicone-coated 4-0 nylon monofilament suture was inserted through an incision of the external cerebral artery and gently advanced 17.0 ± 2.0 mm to occlude the middle cerebral artery. Sham-operated rats underwent the same surgical procedures as their ischemic counterparts but without suture-induced occlusion. The neurological behavior status was carefully evaluated at 24 hours after surgery according to Bederson\'s method\[[@ref37]\]. A higher score indicated worse neurobehavioral dysfunction, vice versa. Rats that scored 1--3 were included in the subsequent experiments.

### *Buyang Huanwu* Decoction treatments {#sec3-4}

Rats in the treatment group were orally gavaged with 5 g/kg *Buyang Huanwu* Decoction per day. The dosage was based on a clinical regimen for adult patients. The animals in other groups were given the same volume of distilled water.

### BrdU labeling {#sec3-5}

To measure cell proliferation, animals received daily i.p. injections of BrdU (50 mg/kg per day; Sigma, St. Louis, MO, USA) in the first week after the occlusion and twice a week (5^th^, 7^th^ days) thereafter. BrdU incorporation into DNA was used as an index of dividing cells and their progeny\[[@ref38]\].

### Tissue preparation {#sec3-6}

Animals were killed at 1, 7, 14 and 28 days after onset of middle cerebral artery occlusion under anesthesia and then perfused transcardially with saline solution, followed by 4% (w/v) paraformaldehyde. The brains were removed and fixed in 0.01 mol/L PBS containing 4% (w/v) cold paraformaldehyde for 24 hours. The fixed tissues were transferred to 30% (w/v) sucrose solution and kept at 4°C. Subsequently, the specimens were cut into 15 μm slices with a cryostat and mounted onto silane-coated slides. After they were dried at 37°C for 60 minutes, the sections were stored at --70°C for examination by microscopy (Olympus, Tokyo, Japan).

### Immunohistochemical detection {#sec3-7}

To monitor neural stem cells, we immunostained cells for nestin, which is an intermediate filament protein, transiently and abundantly expressed early in embryogenesis\[[@ref39]\], *e.g*., in neuroepithelium. Five brain tissue sections from rats killed at each time point were incubated in horse serum blocking solution for 10 minutes and then in primary antibody (mouse anti-nestin monoclonal antibody, 1:500; Chemicon, Millipore, Billerica, MA, USA) for 2 hours at room temperature. The slides were washed with 0.01 mol/L PBS containing 0.1% (v/v) Triton X-100 and incubated with a biotinylated secondary broad goat anti-mouse IgG antibody (Zymed Laboratories, Inc., San Francisco, CA, USA). After additional incubation with streptavidin peroxidase, the slides were stained with 3-amino-9-ethylcarbazole (Zymed Laboratories). Newborn neurons were identified using double immunohistochemistry, as described in the protocol of the Histostain-DS kit (Zymed Laboratories).

Briefly, endogenous peroxidase activity was quenched by 30-minute incubation in freshly prepared 3% (v/v) H~2~O~2~-methanol solution. The sections were pretreated with 2 mol/L HCl for 10 minutes at room temperature to denature DNA and then blocked for 10 minutes at room temperature with horse serum blocking solution. A mouse anti-BrdU antibody (1:100; ThermoFisher Scientific, Sunnyvale, CA, USA) diluted in PBS was added and allowed to incubate for 1 hour at 37°C. Anti-BrdU was initially detected by streptavidin-alkaline phosphatase and stained with 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium salt. The same staining procedure was repeated by incubating brain sections with the neuron-specific marker mouse anti-MAP-2 antibody (1:400; Millipore). Immunolabeling was detected with the biotinylated secondary broad IgG (1:400; Zymed Laboratories) followed by streptavidin-peroxidase and stained with AEC. The expression of mouse anti-GAP-43 (1:200; Zymed Laboratories) was monitored using immunohistochemistry as described above.

Nestin-positive cells had intense red cytoplasmic staining. Three coronal brain sections were randomly selected. The number of nestin, BrdU/MAP-2 and GAP-43 positive cells per mm^2^ of area was calculated through the use of Olympus MicroImage 4.0 software (Olympus).

### Statistical analysis {#sec3-8}

Measurement data are expressed as mean ± SD. Statistical analysis was performed using the Student\'s *t*-test, with SPSS 11.0 software (SPSS, Chicago, IL, USA). *P* \< 0.05 was considered statistically significant.
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